Israel Blood Plasma Derivative Market (2025-2031) | Industry, Share, Analysis, Outlook, Trends, Forecast, Segmentation, Companies, Value, Competitive Landscape, Growth, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F

3.3 Israel Blood Plasma Derivative Market - Industry Life Cycle

3.4 Israel Blood Plasma Derivative Market - Porter's Five Forces

3.5 Israel Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Israel Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring blood plasma derivatives

4.2.2 Technological advancements in the production and purification of blood plasma derivatives

4.2.3 Growing demand for immunoglobulins and other plasma-derived products for therapeutic purposes

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the production and distribution of blood plasma derivatives

4.3.2 High cost associated with the production and storage of blood plasma derivatives

4.3.3 Limited availability of plasma donors and challenges in ensuring a stable and safe supply chain for plasma collection

6.1 Israel Blood Plasma Derivative Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F

6.1.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F

6.1.5 Israel Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F

6.1.6 Israel Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F

6.1.7 Israel Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F

6.1.8 Israel Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Blood Plasma Derivative Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F

6.2.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F

6.2.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F

6.2.5 Israel Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Blood Plasma Derivative Market, By End User

6.3.1 Overview and Analysis

6.3.2 Israel Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Israel Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F

6.3.4 Israel Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F

7.1 Israel Blood Plasma Derivative Market Export to Major Countries

7.2 Israel Blood Plasma Derivative Market Imports from Major Countries

8.1 Average selling price of blood plasma derivatives

8.2 Number of approved indications for blood plasma derivative products

8.3 Research and development investments in improving the efficiency of plasma fractionation processes

9.1 Israel Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Israel Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Israel Blood Plasma Derivative Market Revenue Share, By Companies, 2024

10.2 Israel Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters